Ella Sklan

Title: Ella Sklan: Innovator in Targeted Cancer Therapy

Introduction

Ella Sklan is a prominent inventor based in Raanana, Israel. She has made significant contributions to the field of cancer therapy, particularly through her innovative work involving microRNA technology. With a total of 2 patents, her inventions are paving the way for new treatment options in oncology.

Latest Patents

Ella Sklan's latest patents focus on a groundbreaking approach to cancer treatment. One of her notable inventions is the MIR-21 promoter driven targeted cancer therapy. This invention provides a nucleic acid construct that comprises a promoter sequence derived from microRNA-21 (miR-21) linked to a nucleic acid sequence encoding an anti-cancer agent, such as a toxin. The constructs developed through this invention are particularly useful for treating tumors that express miR-21.

Career Highlights

Throughout her career, Ella has worked with various institutions, including Tel Aviv University. Her research and innovations have garnered attention in the scientific community, contributing to advancements in targeted cancer therapies.

Collaborations

Ella has collaborated with notable colleagues, including Alona Zilberberg and Naama David. These partnerships have enhanced her research efforts and expanded the impact of her inventions.

Conclusion

Ella Sklan is a remarkable inventor whose work in targeted cancer therapy is making a significant difference in the fight against cancer. Her innovative approaches and collaborations continue to inspire advancements in medical research and treatment options.